Michael A Mussallem Edwards Lifesciences Corp (EW) insider trading activity

Michael A Mussallem is Director of Edwards Lifesciences Corp. Currently has a direct ownership of 4,485 shares of EW, which is worth approximately $320,901. The most recent transaction as insider was on Oct 14, 2022, when has been sold 19,875 shares (Common Stock) at a price of $83.93 per share, resulting in proceeds of $1,668,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49K

0% 3M change

0% 12M change

Total Value Held $320,901

MICHAEL A MUSSALLEM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 14 2022	SELL Open market or private sale	$1,668,109 $83.93 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Oct 14 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Sep 22 2022	SELL Open market or private sale	$1,682,618 $84.66 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Sep 22 2022	SELL Bona fide gift	-	9,500 Reduced 5.18%	174,027 Common Stock
Sep 22 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Aug 15 2022	SELL Open market or private sale	$2,082,701 $104.79 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Aug 15 2022	SELL Bona fide gift	-	9,500 Reduced 5.2%	173,125 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Jul 14 2022	SELL Open market or private sale	$1,903,429 $95.77 p/Share	19,875 Reduced 10.64%	166,852 Common Stock
Jul 14 2022	SELL Bona fide gift	-	9,500 Reduced 5.69%	157,352 Common Stock
Jul 14 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Jun 14 2022	SELL Open market or private sale	$1,731,112 $87.1 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Jun 14 2022	SELL Bona fide gift	-	9,500 Reduced 5.37%	167,459 Common Stock
Jun 14 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
May 10 2022	SELL Bona fide gift	-	12,500 Reduced 6.83%	170,450 Common Stock
May 10 2022	SELL Open market or private sale	$3,088,019 $94.87 p/Share	32,550 Reduced 17.14%	157,352 Common Stock
May 10 2022	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 18.21%	202,402 Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	56,831 Added 26.53%	157,352 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	21,250 Added 17.45%	100,521 Common Stock
Apr 29 2022	SELL Open market or private sale	$3,511,494 $107.88 p/Share	32,550 Reduced 26.18%	91,771 Common Stock
Apr 29 2022	SELL Bona fide gift	-	12,500 Reduced 13.62%	79,271 Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 26.6%	124,321 Common Stock
Mar 22 2022	SELL Open market or private sale	$3,626,070 $111.4 p/Share	32,550 Reduced 29.11%	79,271 Common Stock
Mar 22 2022	SELL Bona fide gift	-	12,500 Reduced 10.9%	102,220 Common Stock
Mar 22 2022	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 26.6%	124,321 Common Stock

MAM

Michael A Mussallem

Director

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account